JD Vance downplayed the significance of the Watergate scandal during a speech on Thursday, saying that the controversy that toppled President Richard Nixon would be âlike a 12-hour news storyâ if it happened today. https://t.co/TTkFqpGzUG
Great to see @VirusesImmunity last paper highlighted at @NatRevImmunol. One of the strongest pieces of evidence yet for autoimmunity in #LongCOVID.
Not proof that autoimmunity explains all neurological Long COVID, but it's getting harder to dismiss as one important mechanism.
2/5
Lipoprotein(a) â Lp(a).
This is 100% genetic. You can run marathons. Eat perfectly. Still have sky-high levels. 1 in 5 Americans are elevated, which triples heart attack risk.
You only need to check it once in your life because your levels are set at birth. The 2026 ACC/AHA guidelines now recommend everyone be tested.
Most people never have been.
Apolipoprotein B â ApoB.
For decades we've obsessed over LDL cholesterol. But LDL measures the cholesterol inside the particles. ApoB counts every single particle crashing into your artery walls.
A 2024 analysis found that 54% of patients had dangerous ApoB levels that standard LDL testing missed entirely. If you're only looking at LDL, you're driving with one eye closed.
Eight of the top ten officials at the US National Institute of Allergy and Infectious Diseases have now been pushed out since President Donald Trump took office
https://t.co/Rzlr3WUOUv
Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome
đšA nightmare study for many!
FOR EVERYBODY: 9 months after your COVID-19, your blood vessels are STILL damaged, with probably biomarkers to prove it!
1. Study design:
German prospective cohort (n=262 adults) compared blood biomarkers ~37 weeks post-SARS-CoV-2 infection (PCS patients + recovered) versus uninfected controls.
2. Endothelial dysfunction:
- Soluble thrombomodulin (sTM) and lactate dehydrogenase (LDH), two established markers of endothelial (blood-vessel) damage, were significantly elevated in the combined infected group (UOC PCS + LIFE Cov+) versus never-infected controls.
- So, previously infected individuals had significantly higher soluble thrombomodulin (TM) and lactate dehydrogenase (LDH), independent of PCS diagnosis or fatigue severity.
- Critically, there were no significant differences between the PCS group and the LIFE Cov+ group for these markers.
3. Metabolic disruption:
- Clear alterations in arginine biosynthesis and taurine/hypotaurine pathways, indicating impaired nitric-oxide (NO) metabolism with reduced L-arginine and taurine levels.
âIn plain terms: the vascular damage signal was just as strong in the symptom-free recovered people as in those still suffering from fatigue and other PCS complaints. The same held for the metabolic disruptions (impaired arginine biosynthesis and taurine/hypotaurine pathways linked to nitric-oxide production).
4. Fatigue-specific signal:
- High-fatigue PCS patients (top MFI-20 quartile) showed elevated linoleic acid (LA) plus monounsaturated fatty acids oleic (OA) and palmitoleic (PA).
âThe fatty-acid signature specific to high-fatigue PCS adds a potential severity marker.
5. Notes:
- Changes persisted already up to 9 months after infection.
- PCS remains symptom-based, but these markers offer objective, measurable signals of underlying vascular and metabolic damage!
-The discussion and results treat the observed endothelial and metabolic changes as consequences of a single infection and do not speculate on additive damage from subsequent exposures.
- Limitations well noted.
âŒïžSo, COVID-19 leaves detectable, objective blood-vessel and metabolic damage in the bloodstream nearly a year later, even if you feel completely fine and never had Long COVID symptoms.
Specific fatty-acid spikes flag severe post-COVID fatigue. The âitâs all in your headâ narrative for many post-covid people is directly contradicted by these biomarkers!
These findings, solidly backed by prior 2021â2025 evidence, prove that COVID-19 inflicts measurable, persistent endothelial and nitric-oxide metabolic damage up to nearly a year later, even in fully symptom-free survivors, thereby supporting the implementation of routine biomarker screening, but even more importantly: #AvoidSars2 #AvoidReinfections. YOU ARE NOW A CV RISK PATIENT!
https://t.co/dkyr9HXTyO